AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 3 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 8.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $241,000 | -76.9% | 476,404 | +4.9% | 0.00% | -100.0% |
| Q1 2022 | $1,045,000 | -3.3% | 454,093 | +99.6% | 0.00% | 0.0% |
| Q4 2021 | $1,081,000 | +376.2% | 227,508 | +698.2% | 0.00% | – |
| Q3 2021 | $227,000 | -29.1% | 28,503 | -38.0% | 0.00% | – |
| Q2 2021 | $320,000 | -35.6% | 45,981 | -26.7% | 0.00% | – |
| Q1 2021 | $497,000 | -43.5% | 62,747 | -43.8% | 0.00% | -100.0% |
| Q4 2020 | $879,000 | +31.4% | 111,735 | +18.6% | 0.00% | 0.0% |
| Q3 2020 | $669,000 | -22.2% | 94,239 | +1.4% | 0.00% | 0.0% |
| Q2 2020 | $860,000 | +577.2% | 92,958 | +241.2% | 0.00% | – |
| Q1 2020 | $127,000 | -63.2% | 27,242 | -45.9% | 0.00% | – |
| Q2 2019 | $345,000 | +127.0% | 50,378 | +166.5% | 0.00% | – |
| Q1 2019 | $152,000 | – | 18,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |